Form 4 for CAMP Camp4 Therapeutics Corp
Accepted 2026-08-19 20:46:05 ET · period of report 2026-08-19 · accession 0001628280-26-058107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 20:46 | 2026-08-19 | CAMP | Tardiff Daniel | CSO | S - Sale | $4.76 | -1,738 | 0 | -100% | -$8,273 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-19 | S | D | 1,738 | $4.76 | 0 | D | — | — | (F1) The shares sold were previously acquired by the reporting person pursuant to the CAMP4 Therapeutics Corporation Employee Stock Purchase Plan (the "ESPP") for the purchase period of January 1, 2026 through June 30, 2026 in a transaction that was exempt under Rule 16b-3(c). |